Compass Therapeutics to Present at the Piper Sandler 34th Annual Healthcare Conference

Rhea-AI Summary

Compass Therapeutics, a clinical-stage biopharmaceutical company focused on cancer treatment, will participate in the Piper Sandler 34th Annual Healthcare Conference from November 29 to December 1, 2022, in New York City. The company's presentation is scheduled for December 1, 2022, at 8:50 AM ET. A webcast link will be available on their website, and the corporate presentation will be archived for 90 days. Compass Therapeutics is dedicated to developing antibody-based therapies targeting key biological pathways to enhance anti-tumor responses.

BOSTON, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage biopharmaceutical company developing proprietary antibody-based therapeutics to treat cancer, today announced that the Company will participate in the Piper Sandler 34^th Annual Healthcare Conference, which is taking place at the Lotte New York Palace November 29 – December 1, 2022.

Presentation details:

Date: Thursday, December 1, 2022
Time: 8:50 – 9:10 AM ET
Webcast: the link will be available on the Events section of the website

Virtual/Replay availability: The corporate presentation will be archived for 90 days on Compass’ Events page.

About Compass Therapeutics

Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. Compass’s scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. The company pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. These include modulation of the microvasculature via angiogenesis-targeted agents, induction of a potent immune response via activators on effector cells in the tumor microenvironment, and alleviation of immunosuppressive mechanisms used by tumors to evade immune surveillance. Compass plans to advance its product candidates through clinical development as both standalone therapies and in combination with proprietary pipeline antibodies based on supportive clinical and nonclinical data. The company was founded in 2014 and is headquartered in Boston, Massachusetts. For more information, visit the Compass Therapeutics website at https://www.compasstherapeutics.com.

Investor Contact
Mario Corso, Executive Director and Head of Investor Relations
ir@compasstherapeutics.com

Media Contact
Anna Gifford, Communications Manager
media@compasstherapeutics.com
617-500-8099

FAQ

When is Compass Therapeutics participating in the Piper Sandler Healthcare Conference?

Compass Therapeutics will participate in the Piper Sandler 34th Annual Healthcare Conference from November 29 to December 1, 2022.

What time is Compass Therapeutics' presentation at the conference?

Compass Therapeutics' presentation is scheduled for December 1, 2022, from 8:50 to 9:10 AM ET.

How can I access the Compass Therapeutics presentation webcast?

The webcast link for the Compass Therapeutics presentation will be available on the Events section of their website.

Will the Compass Therapeutics presentation be available for replay?

Yes, the Compass Therapeutics corporate presentation will be archived for 90 days after the event.

What is the focus of Compass Therapeutics?

Compass Therapeutics focuses on developing proprietary antibody-based therapeutics to treat cancer, targeting pathways that enhance anti-tumor responses.